Evidence map›Paper›PMID 42045233›Full record

ArticleNature communications2026

DDA-BERT: end-to-end training for data-dependent acquisition mass spectrometry-based proteomics.

Jun A, Pu Liu, Yingying Sun, Jiaying Lin, Xiaofan Zhang, Zongxiang Nie, Jingnan Liu, Zhiguo Yu, Yuqi Zhang, Ziyuan Xing and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jun A *Affiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, China.
Pu Liu *Westlake Omics (Hangzhou) Biotechnology Co., Ltd., Hangzhou, China.
Yingying Sun *Affiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, China.
Jiaying LinAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, China.
Xiaofan ZhangAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, China.
Zongxiang NieWestlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Jingnan LiuAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, China.
Zhiguo YuAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, China.
Yuqi ZhangAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, China.
Ziyuan XingAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, China.
Yi ChenWestlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China. chenyi@westlake.edu.cn.
Tiannan GuoAffiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, China. guotiannan@westlake.edu.cn.ORCID http://orcid.org/0000-0003-3869-7651

Funding

National Natural Science Foundation of China (National Science Foundation of China) U24A20476
6 · The paper itself

Abstract

Peptide-spectrum match (PSM) rescoring is critical for accurate peptide identification in data-dependent acquisition (DDA)-based proteomics. Existing rescoring frameworks typically combine search-engine scores with heuristic or learned auxiliary features to refine PSM ranking and confidence estimation. Although recent approaches incorporate deep learning-derived representations of spectra, retention time, or ion mobility, the final decision stage still commonly relies on separately trained shallow classifiers, constraining the expressive capacity of the overall scoring framework. Here, we introduce DDA-BERT, a transformer-based end-to-end deep learning model trained with ~271 million PSMs from 11 species. DDA-BERT consistently outperforms existing tools across species-specific benchmarks, achieving 2.24%-269.35%, 3.73%-141.46%, 5.53%-45.64%, and 3.68%-62.77% increases in peptide identifications on human, yeast, Drosophila, and Arabidopsis datasets, respectively. The model retains high sensitivity in trace-level proteomics samples. On HLA immunopeptidomics data, DDA-BERT further increases peptide identifications by 4.14%-87.47%. The main limitations of DDA-BERT include the requirement for GPU-based computing and the need for substantial, diverse training datasets to achieve optimal model performance. This study introduces an alternative DDA rescoring approach and establishes a methodological foundation for scalable, AI-driven peptide identification in DDA proteomics.

Indexed as

Deep LearningMass SpectrometryPeptidesProteomicsAnimalsArabidopsisDatabases, ProteinDrosophilaHumansSoftwarePeptides

Identifiers

PMID42045233
PMCPMC13324686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.